Medicare Part B Spending on Macular Degeneration Treatments Associated With Manufacturer Payments to Ophthalmologists
Sean R. Dickson, JD, MPH1,2; Katelyn E. James, BA1 September 8, 2023 Key Points Question Do ophthalmologists who accept payments from manufacturers of age-related macular degeneration (ARMD) drugs prescribe higher-cost therapies? Findings In this cross-sectional study of 2013 to 2019 Medicare Part B data including 21 584 ophthalmologists, ophthalmologists who accepted manufacturer payments from ARMD drug manufacturers were significantly less likely to… Read more »